Product Categories
| Country: | China |
|---|---|
| Tel: | 027-19050701 |
| Mobile: | 13545374703 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Fluticasone furoate impurity EP-ZF; Propan-2-yl 6α,9-difluoro-17α-[(furan-2-ylcarbonyl)oxy]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17-carboxylate | Details |
| Budesonide impurity C | C25H34O6 | 1040085-99-1 | Details |
| Fluticasone Trioxo Impurity | C24H30O5 | 5541-37-7 | Details |
| Axitinib impurity D | C15H13N3OS | 944835-85-2 | Details |
| Budesonide impurity J | C25H33BrO6 | 313474-59-8 | Details |
| Fluticasone furoate impurity EP-ZG | C27H29ClF2O6S | 785806-96-4 | Details |
| Levetiracetam impurity 08 | C9H19ClN2O3 | 81107-75-7 | Details |
| Fluticasone furoate impurity EP-ZH; 6α-Chloro-9-fluoro-17-[[(fluoromethyl)sulfanyl]carbonyl]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl furan-2-carboxylate | Details |
| Budesonide impurity E | C25H32O6 | 131918-64-4 | Details |
| Budesonide impurity D | C25H32O6 | 85234-63-5 | Details |
| Rosuvastatin calcium impurity C | C22H26FN3O6S | 1422619-13-3 | Details |
| Axitinib impurity H | C22H20N4OS | 1443118-73-7 | Details |
| Levetiracetam impurity 10; diethyl 4,4'-((1-methoxy-1-oxobutan-2-yl)azanediyl)dibutyrate | Details |
| Letrozole impurity 05 | C17H13N5O | 2500927-47-7 | Details |
| Phenylephrine impurity A | C16H18ClNO2 | 71786-67-9 | Details |
| fluticasone propionate impurity EP-ZE | C25H33F3O5S | 105613-90-9 | Details |
| Levetiracetam impurity 04 | C8H15ClN2O2 | 102767-31-7 | Details |
| fluticasone propionate impurity EP-ZH | C48H58F4O10S2 | 201812-64-8 | Details |
| Budesonide impurity B | C23H30O6 | 1040085-98-0 | Details |
| Vortioxetine Sulfone | C18H22N2O2S | 1639263-80-1 | Details |
| Axitinib impurity G | C44H36N8O2S2 | 1428728-83-9 | Details |
| Phenylephrine impurity D | C8H12ClNO2 | 636-87-3 | Details |
| Palbociclib impurity 02 | C22H27N7O2 | 571191-15-6 | Details |
| Fluticasone furoate impurity EP-ZA | C26H28F2O7 | 397864-63-0 | Details |
| Fluticasone furoate impurity EP-ZE | C25H31F3O5S | 398454-97-2 | Details |
| 11-Oxo-Fluticasone Furoate | C26H26F2O6S | 397864-57-2 | Details |
| Budesonide impurity F | C24H32O6 | 638-94-8 | Details |
| Letrozole impurity 07 | C10H7ClN4 | 2451658-74-3 | Details |
| Phenylephrine impurity B | C9H12ClNO2 | 94240-17-2 | Details |
| Olanzapine impurity B | C12H10N2OS | 221176-49-4 | Details |
| Olanzapine impurity A | C12H9N3O2S | 138564-59-7 | Details |
| Levetiracetam impurity 05 | C10H19NO4 | 1342229-32-6 | Details |
| Fluticasone furoate impurity EP-ZB | C24H29F3O5S | 80474-24-4 | Details |
| fluticasone propionate impurity EP-ZD | C25H32F2O5S | 73205-13-7 | Details |
| Levetiracetam impurity 06 | C8H15NO4 | 1543353-92-9 | Details |
| Budesonide impurity H | C25H32O5 | 313474-58-7 | Details |
| Budesonide impurity I | C25H34O7 | 113930-13-5 | Details |
| Palbociclib impurity 09 | C13H14BrN3O2 | 1922954-32-2 | Details |
| Palbociclib impurity 11 | C41H55N11O5 | 2206135-30-8 | Details |
| 3-Bromo-vortioxetine Hydrobromide | 2725536-51-4 | Details |
| Rosuvastatin calcium impurity E | C38H46F2N6O9S2 | 2226413-61-0 | Details |
| Olanzapine impurity F | C12H12ClN3S | 138564-60-0 | Details |
| Levetiracetam impurity A | C8H13NO3 | 67118-31-4 | Details |
| Fluticasone furoate impurity EP-ZJ; 6α,9-Difluoro-17-[[(fluoromethyl)sulfanyl]carbonyl]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl 5-chlorofuran-2-carboxylate | Details |
| Letrozole impurity 08; 1-(bis(4-cyanophenyl)methyl)-1H-1,2,4-triazole 4-oxide | Details |
| Rosuvastatin calcium impurity F | C29H40FN3O6S | 289042-12-2 | Details |
| Phenylephrine impurity C | C16H19NO2 | 1159977-09-9 | Details |
| Palbociclib impurity 54 | C9H14N4 | 1082876-26-3 | Details |
| Olanzapine impurity C | C18H22Cl2N4S | 719300-59-1 | Details |
| Rosuvastatin calcium impurity D | C22H26FN3O5S | 1422954-11-7 | Details |
| Palbociclib impurity 13 | C29H37N7O4 | 1651214-74-2 | Details |
| Fluticasone Furoate Trisulphane | Details |
| fluticasone propionate impurity EP-ZB | C24H30F2O6S | 948566-12-9 | Details |
| Axitinib impurity I | C22H18N4O3S | 1348536-59-3 | Details |
| Palbociclib impurity 10 | C24H29N7O | 2204863-06-7 | Details |
| Levetiracetam impurity C | C8H11N | 3886-69-9 | Details |
| Palbociclib impurity 03 | C13H12Br2ClN3O | 2324831-15-2 | Details |
| 1,4-Bis[2-[(2,4-dimethylphenyl)thio]phenyl]piperazine | C32H34N2S2 | 2243045-82-9 | Details |
| Axitinib impurity C | C17H15N3O3S | 1959572-98-5 | Details |
| Phenylephrine impurity E | C10H9BrO3 | 38396-89-3 | Details |
| Axitinib impurity E | C15H12IN3OS | 885126-34-1 | Details |
| fluticasone propionate impurity EP-ZI | C48H58F4O10S3 | 960071-64-1 | Details |
| Olanzapine impurity H | C18H20N4OS | 935272-10-9 | Details |
| N-formyl Vortioxetine | C19H22N2OS | 2135576-73-5 | Details |
| Palbociclib impurity 07 | C33H45N7O4 | 827022-35-5 | Details |
| Rosuvastatin calcium impurity A | C25H34FN3O7S | 1715120-13-0 | Details |
| N-Acetyl Vortioxetine | C20H24N2OS | 1801352-86-2 | Details |
| Levetiracetam impurity 11 | C10H12O5 | 93778-15-5 | Details |
| Phenylephrine impurity F; 3-(2,2-dibromoacetyl)phenyl acetate | Details |
| Palbociclib impurity01; 6-acetyl-8-cyclopentyl-2-((5-(ethylamino)pyridin-2-yl)amino)-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | Details |
| Desethylene Vortioxetine | C16H20N2S | 2831955-36-1 | Details |
| Desonide 21-Acetate | C26H34O7 | 25092-25-5 | Details |
| Budesonide impurity A | C21H28O6 | 13951-70-7 | Details |
| Axitinib impurity B | C15H12IN3O2S | 1443118-71-5 | Details |
| Levetiracetam impurity 09 | C8H16N2O3 | 1868118-63-1 | Details |
| fluticasone propionate impurity EP-ZA | C24H30F2O6 | 65429-42-7 | Details |
| Olanzapine impurity D | C17H20N4OS | 174794-02-6 | Details |
| Phenylephrine impurity H | C9H13NO2 | 1477-63-0 | Details |
| Olanzapine impurity E | C16H18N4S | 161696-76-0 | Details |
| 3-[(2,4-Dimethylphenyl)thio]benzenamine | C14H15NS | 1184281-83-1 | Details |
| Budesonide impurity K | C27H36O7 | 51333-05-2 | Details |
| Fluticasone propionate impurity EP-ZG | C43H51F5O8S | 220589-37-7 | Details |
| Axitinib impurity F | C22H18N4OS | 885126-40-9 | Details |
| Palbociclib impurity 12 | C24H29N7O3 | 2174002-29-8 | Details |
| Rosuvastatin calcium impurity J | C38H44F2N6O8S2 | 2226413-62-1 | Details |
| Fluticasone Furoate 1,2 Dihydro Sulfenic Acid | C26H28F2O7S | 948566-11-8 | Details |
| Levetiracetam impurity 07 | C8H17ClN2O3 | 429673-89-2 | Details |
| Axitinib impurity A | C15H13N3O2S | 1959572-97-4 | Details |
| Phenylephrine impurity G | C9H14ClNO2 | 939-38-8 | Details |
| Chloro Fluticasone Propionate | C25H31ClF2O5S | 80486-69-7 | Details |
| Rosuvastatin calcium impurity B | C22H28FN3O6S | 1094100-06-7 | Details |
| Budesonide impurity L | C25H32O6 | 216453-74-6 | Details |
| fluticasone propionate impurity EP-ZF | C25H29F3O5S | 1219174-94-3 | Details |
| Fluticasone Trioxo Impurity | C22H24F2O5S | 219719-95-6 | Details |
| Budesonide impurity G | C25H36O6 | 137174-25-5 | Details |
| Olanzapine impurity G | C28H26N6S2 | 1070876-09-3 | Details |
| Chloro Fluticasone Furoate | C27H29ClF2O6S | 1374153-88-4 | Details |
| Fluticasone furoate impurity EP-ZI | C27H29F3O7S | 948569-98-0 | Details |
| N-Methyl Vortioxetine Hydrobromide | C19H24N2S | 1293489-87-8 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 | ||||